Medpace Holdings (MEDP) reported fiscal Q1 earnings late Monday of $3.67 per diluted share, up from $3.20 a year earlier.
Analysts polled by FactSet expected $3.06.
Revenue for the quarter ended March 31 was $558.6 million, up from $511.0 million a year ago. Analysts expected $526.3 million.
For full-year 2025, the company said it now expects EPS of $12.26 to $13.04 on revenue of $2.14 billion to $2.24 billion.
In February, it forecast 2025 EPS of $11.93 to $12.69 on revenue of $2.11 billion to $2.21 billion. Analysts expected EPS of $12.24 on revenue of $2.14 billion.